RT Journal Article
SR Electronic
T1 Characterization of Human Cellular γ-Glutamyl Hydrolase
JF Molecular Pharmacology
JO Mol Pharmacol
FD American Society for Pharmacology and Experimental Therapeutics
SP 1040
OP 1046
VO 53
IS 6
A1 M. S. Rhee
A1 B. Lindau-Shepard
A1 K. J. Chave
A1 J. Galivan
A1 T. J. Ryan
YR 1998
UL http://molpharm.aspetjournals.org/content/53/6/1040.abstract
AB A previously identified cDNA encoding a human γ-glutamyl hydrolase was expressed in a baculovirus system. The expressed protein had molecular mass of 37 kDa. Treatment of the protein with PNGase F produced a protein of molecular mass of 30 kDa, indicating that the protein contained asparagine-linked glycosylation. Sequence analysis of the expressed protein indicated that a 24-amino-acid signal peptide had been removed. A polyclonal antibody to the expressed enzyme was used in Western blot analysis of partially purified lysates of HL-60 promyeloid leukemia cells and MCF-7 breast cancer cells. The HL-60 and MCF-7 enzymes appeared as two closely spaced bands with a molecular mass of 37 kDa. Treatment of the HL-60 enzyme with PNGase F produced a protein with a molecular mass of 30 kDa. The activities of the expressed enzyme and the enzyme from HL-60 cells were similar on methotrexate polyglutamates. Methotrexate-γ-Glu is a poor substrate for the human enzyme relative to methotrexate γ-Glu2–5. During hydrolysis of methotrexate-γ-Glu4, all possible pterin-containing cleavage products (methotrexate and methotrexate-γ-Glu1–3) appear. The results demonstrated that the human enzyme cleaves both the ultimate and penultimate γ-linkages of methotrexate polyglutamates. Glutamate was released as either glutamic acid or γ-Glu2. Longer chain species of γ-Glun>2 were not observed. Inhibition by iodoacetic acid suggested that both the expressed enzyme and the HL-60 enzyme may contain a catalytically essential cysteine. These results indicate that the identified cDNA encodes the intracellular γ-glutamyl hydrolase found in a variety of human tumor cells and that the baculovirus-expressed enzyme is a suitable model for further structural and enzymatic studies. The American Society for Pharmacology and Experimental Therapeutics